Neurocrine Biosciences Insider Trades
NASDAQ: NBIXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 142.44 0.00%
Last 12 months
- Purchases
- 0 · $0
- Sales
- 27 · $22.50M
- Shares bought / sold
- 0 / 136.81K
- Net activity
- Net selling $22.5 million
Neurocrine Biosciences insider activity
Over the last 12 months, Neurocrine Biosciences insiders reported 73 transactions on SEC Form 4: 0 open-market purchases and 27 sales. Insiders bought $0 and sold $22.5 million worth of stock, for net insider selling of $22.5 million. The largest seller was Cooke Julie, with $5.8 million in reported sales.
The most recent filing shows Boyer David W. (Chief Corp. Affairs Officer) selling 826 shares at $157.45 on Sep 14, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put NBIX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
NBIX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 14, 2026 | ABERNETHY MATTChief Financial Officer | Sale | 2,311 | $363.28K | Form 4 |
| Sep 14, 2026 | Boyer David W.Chief Corp. Affairs Officer | Sale | 826 | $130.05K | Form 4 |
| Sep 11, 2026 | ABERNETHY MATTChief Financial Officer | Tax withholding | 2,709 | $423.20K | Form 4 |
| Sep 11, 2026 | ABERNETHY MATTChief Financial Officer | Award | 5,020 | — | Form 4 |
| Sep 11, 2026 | BENEVICH ERICChief Commercial Officer | Tax withholding | 3,386 | $528.96K | Form 4 |
| Sep 11, 2026 | BENEVICH ERICChief Commercial Officer | Award | 6,275 | — | Form 4 |
| Sep 11, 2026 | Boyer David W.Chief Corp. Affairs Officer | Tax withholding | 1,936 | $302.44K | Form 4 |
| Sep 11, 2026 | Boyer David W.Chief Corp. Affairs Officer | Award | 3,587 | — | Form 4 |
| Sep 11, 2026 | Cooke JulieChief Human Resources Officer | Tax withholding | 1,936 | $302.44K | Form 4 |
| Sep 11, 2026 | Cooke JulieChief Human Resources Officer | Award | 3,587 | — | Form 4 |
| Sep 11, 2026 | GORMAN KEVIN CHARLESDirector | Tax withholding | 7,839 | $1.22M | Form 4 |
| Sep 11, 2026 | GORMAN KEVIN CHARLESDirector | Award | 14,343 | — | Form 4 |
| Sep 11, 2026 | Lippoldt DarinChief Legal Officer | Tax withholding | 2,419 | $377.90K | Form 4 |
| Sep 11, 2026 | Lippoldt DarinChief Legal Officer | Award | 4,483 | — | Form 4 |
| Sep 11, 2026 | Onyia JudeChief Scientific Officer | Tax withholding | 1,936 | $302.44K | Form 4 |
| Sep 11, 2026 | Onyia JudeChief Scientific Officer | Award | 3,587 | — | Form 4 |
| Sep 11, 2026 | Delaet IngridChief Regulatory Officer | Tax withholding | 2,419 | $377.90K | Form 4 |
| Sep 11, 2026 | Delaet IngridChief Regulatory Officer | Award | 4,483 | — | Form 4 |
| Sep 11, 2026 | Gano KyleChief Executive Officer | Tax withholding | 994 | $155.28K | Form 4 |
| Sep 11, 2026 | Gano KyleChief Executive Officer | Award | 1,842 | — | Form 4 |
| Sep 11, 2026 | Gano KyleChief Executive Officer | Tax withholding | 3,386 | $528.96K | Form 4 |
| Sep 11, 2026 | Gano KyleChief Executive Officer | Award | 6,275 | — | Form 4 |
| Sep 11, 2026 | Keswani Sanjay ChandruChief Medical Officer | Tax withholding | 2,112 | $329.94K | Form 4 |
| Sep 11, 2026 | Keswani Sanjay ChandruChief Medical Officer | Award | 3,914 | — | Form 4 |
| Sep 9, 2026 | BENEVICH ERICChief Commercial Officer | Sale | 2,154 | $333.03K | Form 4 |
| Sep 9, 2026 | BENEVICH ERICChief Commercial Officer | Option exercise | 3,194 | $138.11K | Form 4 |
| Sep 2, 2026 | SHERWIN STEPHEN ADirector | Gift | 1,000 | — | Form 4 |
| Aug 4, 2026 | Onyia JudeChief Scientific Officer | Gift | 2,409 | — | Form 4 |
| Jul 29, 2026 | Norwalk Leslie VDirector | Option exercise | 842 | $117.40K | Form 4 |
| Jul 28, 2026 | Norwalk Leslie VDirector | Sale | 1,250 | $227.51K | Form 4 |
| Jul 10, 2026 | Delaet IngridChief Regulatory Officer | Sale | 4,367 | $790.51K | Form 4 |
| Jul 10, 2026 | Delaet IngridChief Regulatory Officer | Option exercise | 4,367 | $462.99K | Form 4 |
| Jul 9, 2026 | Delaet IngridChief Regulatory Officer | Sale | 8,433 | $1.51M | Form 4 |
| Jul 9, 2026 | Delaet IngridChief Regulatory Officer | Option exercise | 8,433 | $872.98K | Form 4 |
| Jul 9, 2026 | Lippoldt DarinChief Legal Officer | Sale | 10,000 | $1.80M | Form 4 |
| Jul 9, 2026 | Lippoldt DarinChief Legal Officer | Option exercise | 10,000 | $814.90K | Form 4 |
| Jul 8, 2026 | Delaet IngridChief Regulatory Officer | Sale | 2,737 | $488.67K | Form 4 |
| Jul 8, 2026 | Delaet IngridChief Regulatory Officer | Option exercise | 2,737 | $283.33K | Form 4 |
| Jul 7, 2026 | Delaet IngridChief Regulatory Officer | Sale | 3,401 | $607.31K | Form 4 |
| Jul 7, 2026 | Delaet IngridChief Regulatory Officer | Option exercise | 3,401 | $352.07K | Form 4 |
| Jun 29, 2026 | Lippoldt DarinChief Legal Officer | Sale | 1,690 | $288.68K | Form 4 |
| Jun 29, 2026 | Lippoldt DarinChief Legal Officer | Option exercise | 1,690 | $137.72K | Form 4 |
| Jun 29, 2026 | Lippoldt DarinChief Legal Officer | Sale | 8,110 | $1.38M | Form 4 |
| Jun 29, 2026 | Lippoldt DarinChief Legal Officer | Option exercise | 8,110 | $660.88K | Form 4 |
| Jun 26, 2026 | Lippoldt DarinChief Legal Officer | Sale | 200 | $33.91K | Form 4 |
| Jun 26, 2026 | Lippoldt DarinChief Legal Officer | Option exercise | 200 | $16.30K | Form 4 |
| Jun 5, 2026 | Onyia JudeChief Scientific Officer | Gift | 2,441 | — | Form 4 |
| Jun 5, 2026 | SHERWIN STEPHEN ADirector | Sale | 1,843 | $308.36K | Form 4 |
| Jun 5, 2026 | SHERWIN STEPHEN ADirector | Sale | 5,829 | $970.86K | Form 4 |
| Jun 5, 2026 | SHERWIN STEPHEN ADirector | Sale | 6,896 | $1.14M | Form 4 |
| Jun 5, 2026 | SHERWIN STEPHEN ADirector | Sale | 2,549 | $419.16K | Form 4 |
| Jun 5, 2026 | SHERWIN STEPHEN ADirector | Sale | 7,883 | $1.29M | Form 4 |
| Jun 5, 2026 | SHERWIN STEPHEN ADirector | Option exercise | 10,000 | $797.90K | Form 4 |
| Jun 5, 2026 | SHERWIN STEPHEN ADirector | Option exercise | 15,000 | $804.60K | Form 4 |
| Jun 4, 2026 | Norwalk Leslie VDirector | Sale | 1,250 | $210.07K | Form 4 |
| Jun 2, 2026 | Cooke JulieChief Human Resources Officer | Sale | 3,520 | $558.24K | Form 4 |
| Jun 2, 2026 | Cooke JulieChief Human Resources Officer | Sale | 9,521 | $1.50M | Form 4 |
| Jun 2, 2026 | Cooke JulieChief Human Resources Officer | Sale | 4,216 | $660.93K | Form 4 |
| Jun 2, 2026 | Cooke JulieChief Human Resources Officer | Sale | 5,466 | $849.73K | Form 4 |
| Jun 2, 2026 | Cooke JulieChief Human Resources Officer | Sale | 14,214 | $2.20M | Form 4 |
| Jun 2, 2026 | Cooke JulieChief Human Resources Officer | Option exercise | 24,965 | $2.03M | Form 4 |
| Jun 2, 2026 | Keswani Sanjay ChandruChief Medical Officer | Tax withholding | 1,733 | $268.34K | Form 4 |
| Jun 2, 2026 | Keswani Sanjay ChandruChief Medical Officer | Option exercise | 3,212 | — | Form 4 |
| Jun 1, 2026 | Onyia JudeChief Scientific Officer | Sale | 11,000 | $1.76M | Form 4 |
| Jun 1, 2026 | Onyia JudeChief Scientific Officer | Option exercise | 11,000 | $932.14K | Form 4 |
| May 29, 2026 | Delaet IngridChief Regulatory Officer | Sale | 2,261 | $354.32K | Form 4 |
| May 29, 2026 | Delaet IngridChief Regulatory Officer | Option exercise | 2,261 | $178.66K | Form 4 |
| May 27, 2026 | Onyia JudeChief Scientific Officer | Sale | 11,000 | $1.71M | Form 4 |
| May 27, 2026 | Onyia JudeChief Scientific Officer | Option exercise | 11,000 | $932.14K | Form 4 |
| May 26, 2026 | Boyer David W.Chief Corp. Affairs Officer | Sale | 3,888 | $609.02K | Form 4 |
| May 21, 2026 | RASTETTER WILLIAM HDirector | Option exercise | 3,318 | — | Form 4 |
| May 21, 2026 | Sharp ShaliniDirector | Option exercise | 1,659 | — | Form 4 |
| May 21, 2026 | SHERWIN STEPHEN ADirector | Option exercise | 3,318 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4